Fulcrum Therapeutics (FULC) Shareholder's Equity (2018 - 2026)
Fulcrum Therapeutics (FULC) Shareholder's Equity (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
502.95 Mn |
| 10 |
Fulcrum Therapeutics |
267.90 Mn |
267.90 Mn |
- |
333.30 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
333.30 Mn |
| Dec 31, 2025 |
349.00 Mn |
| Sep 30, 2025 |
198.37 Mn |
| Jun 30, 2025 |
214.38 Mn |
| Mar 31, 2025 |
228.49 Mn |
| Dec 31, 2024 |
243.03 Mn |
| Sep 30, 2024 |
257.29 Mn |
| Jun 30, 2024 |
273.79 Mn |
| Mar 31, 2024 |
213.59 Mn |
| Dec 31, 2023 |
235.19 Mn |
| Sep 30, 2023 |
255.46 Mn |
| Jun 30, 2023 |
275.43 Mn |
| Mar 31, 2023 |
296.26 Mn |
| Dec 31, 2022 |
198.94 Mn |
| Sep 30, 2022 |
221.41 Mn |
| Jun 30, 2022 |
160.76 Mn |
| Mar 31, 2022 |
189.16 Mn |
| Dec 31, 2021 |
211.54 Mn |
| Sep 30, 2021 |
230.61 Mn |
| Jun 30, 2021 |
110.89 Mn |
